Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

enzalutamide 4pembrolizumab 3Docetaxel 3apalutamide 2Testosterone 2Prednisone 2Cholecalciferol 2Celecoxib 2Androgen Antagonists 2Abiraterone Acetate 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2relugolix 1olaparib 1nilutamide 1histrelin 1gallium 68 PSMA-11 1capivasertib 1bicalutamide 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abiraterone 1Yoga 1Triptorelin Pamoate 1Tablets 1Simvastatin 1Sildenafil Citrate 1Pluvicto 1Perioperative Care 1Pentoxifylline 1Methylprednisolone 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Prostatic Neoplasms × Insemination, Artificial, Heterologous × Clear all
NCT00012935 2015-04-07

Treatment Decision Intervention for Veterans With Prostate Cancer

VA Office of Research and Development

Phase NA Completed
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡